273 related articles for article (PubMed ID: 30830422)
21. Metabolic signatures of osteoarthritis in urine using liquid chromatography-high resolution tandem mass spectrometry.
Abdelrazig S; Ortori CA; Doherty M; Valdes AM; Chapman V; Barrett DA
Metabolomics; 2021 Mar; 17(3):29. PubMed ID: 33655418
[TBL] [Abstract][Full Text] [Related]
22. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics.
Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B
J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476
[TBL] [Abstract][Full Text] [Related]
23. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
[TBL] [Abstract][Full Text] [Related]
24. Low levels of serum serotonin and amino acids identified in migraine patients.
Ren C; Liu J; Zhou J; Liang H; Wang Y; Sun Y; Ma B; Yin Y
Biochem Biophys Res Commun; 2018 Feb; 496(2):267-273. PubMed ID: 29294327
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker.
Stoitchkov K; Letellier S; Garnier JP; Bousquet B; Tsankov N; Morel P; Ghanem G; Le Bricon T
Melanoma Res; 2003 Dec; 13(6):587-93. PubMed ID: 14646622
[TBL] [Abstract][Full Text] [Related]
26. First-trimester metabolomic prediction of stillbirth.
Bahado-Singh RO; Syngelaki A; Mandal R; Han B; Li L; Bjorndahl TC; Wang N; Maulik D; Dong E; Turkoglu O; Tseng CL; Zeb A; Redman M; Wishart DS; Nicolaides KH
J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3435-3441. PubMed ID: 29712497
[No Abstract] [Full Text] [Related]
27. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study.
Peña-Martín J; Belén García-Ortega M; Palacios-Ferrer JL; Díaz C; Ángel García M; Boulaiz H; Valdivia J; Jurado JM; Almazan-Fernandez FM; Arias Santiago S; Vicente F; Del Val C; Pérez Del Palacio J; Marchal JA
Br J Dermatol; 2024 Apr; 190(5):740-750. PubMed ID: 38214572
[TBL] [Abstract][Full Text] [Related]
28. A pilot case-control study of urine metabolomics in preterm neonates with necrotizing enterocolitis.
Thomaidou A; Chatziioannou AC; Deda O; Benaki D; Gika H; Mikros E; Agakidis C; Raikos N; Theodoridis G; Sarafidis K
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():10-21. PubMed ID: 30991202
[TBL] [Abstract][Full Text] [Related]
29. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
[TBL] [Abstract][Full Text] [Related]
30. Discovery of metabolomic biomarkers for discriminating platinum-sensitive and platinum-resistant ovarian cancer by using GC-MS.
Eroglu EC; Tunug S; Geckil OF; Gulec UK; Vardar MA; Paydas S
Eur J Mass Spectrom (Chichester); 2021 Dec; 27(6):235-248. PubMed ID: 34806450
[TBL] [Abstract][Full Text] [Related]
31. Identification of Potential Biomarkers and Metabolic Profiling of Serum in Ovarian Cancer Patients Using UPLC/Q-TOF MS.
Yang W; Mu T; Jiang J; Sun Q; Hou X; Sun Y; Zhong L; Wang C; Sun C
Cell Physiol Biochem; 2018; 51(3):1134-1148. PubMed ID: 30476914
[TBL] [Abstract][Full Text] [Related]
32. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
33. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
34. LC-Q-TOF-MS based plasma metabolomic profile of subclinical pelvic inflammatory disease: A pilot study.
Zou W; Wen X; Xie C; Nie L; Zhou Q; Chen X; Fang C; Wang Y; Zhang L
Clin Chim Acta; 2018 Aug; 483():164-169. PubMed ID: 29709453
[TBL] [Abstract][Full Text] [Related]
35. Highly-accurate metabolomic detection of early-stage ovarian cancer.
Gaul DA; Mezencev R; Long TQ; Jones CM; Benigno BB; Gray A; Fernández FM; McDonald JF
Sci Rep; 2015 Nov; 5():16351. PubMed ID: 26573008
[TBL] [Abstract][Full Text] [Related]
36. Fermented barley extracts with Lactobacillus plantarum dy-1 changes serum metabolomic profiles in rats with high-fat diet-induced obesity.
Zhang J; Xiao X; Dong Y; Zhou X
Int J Food Sci Nutr; 2019 May; 70(3):303-310. PubMed ID: 30246576
[TBL] [Abstract][Full Text] [Related]
37. Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults.
Bagheri M; Djazayery A; Farzadfar F; Qi L; Yekaninejad MS; Aslibekyan S; Chamari M; Hassani H; Koletzko B; Uhl O
Lipids Health Dis; 2019 Apr; 18(1):94. PubMed ID: 30967146
[TBL] [Abstract][Full Text] [Related]
38. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
39. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]